We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Medica 2025 Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Molecular Diagnostics

Image: Stages of progression of non-alcoholic fatty liver disease (Photo courtesy of Wikimedia Commons)

Blood Test Predicts Likelihood that Nonalcoholic Fatty Liver Disease Will Progress to Liver Cancer

A bioinformatics approach was used to transform a 133-gene panel, which could predict the likelihood of a patient with nonalcoholic fatty liver disease (NAFLD) progressing to hepatocellular carcinoma (HCC), into an easily performed four-protein blood test. More...
23 Jun 2022
Image: Professor Colin Raston and Dr Xuan Luo with a VFD (Photo courtesy of Flinders University)

High-Tech Method for Protein Biomarker Assay Testing to Revolutionize POC Diagnosis

A speedy high-tech method of inexpensive, accurate and high-throughput protein biomarker assay testing is being touted as a much-needed development in point-of-care (PoC) testing. More...
23 Jun 2022
Image: PromarkerD blood test assesses risk of diabetic kidney disease in patients with type 2 diabetes (Photo courtesy of Proteomics)

Blood Test Detects Unique ‘Fingerprint’ of Early Onset of Diabetic Kidney Disease

A blood test that assess the risk of diabetic kidney disease (DKD) in patients with type 2 diabetes has also demonstrated the potential to predict late-stage, as well as early-stage, renal decline. More...
23 Jun 2022
Image: New blood biomarker identified for status of fatty liver disease (Photo courtesy of Medical University Vienna)

Blood Test Can Determine Liver Disease Progression

Researchers have identified the role of a specific subtype of macrophages (white blood cells) in progressive non-alcoholic fatty liver disease that have a protective function against fibrosis and liver cirrhosis, while also being useful as biomarkers of liver disease progression as they can be measured by a blood test. More...
22 Jun 2022
Image: The first metabolism-based multi-cancer early detection test is expected to become commercially available (Photo courtesy of Pexels)

Metabolism-Based Blood Test to Detect Multiple Cancer Types Prior to Symptoms

A pioneering metabolism-based liquid biopsy could detect any-type cancer in adults who show no symptoms or have any recent history of cancer, thereby preventing cancer mortality through early detection. More...
22 Jun 2022
Image: New test could detect protein ‘fingerprints’ in the blood (Photo courtesy of Pexels)

Simple Blood Test for Esophageal Cancer Could Reduce Invasive Endoscopy Procedures

A simple blood test targeted at patients with Barrett’s esophagus could detect biomarkers for esophageal adenocarcinoma that were already validated in a 300 patient study earlier this year. More...
22 Jun 2022
Image: Dragonfly is a cost-effective point-of-need portable diagnostic system for infectious diseases (Photo courtesy of ProtonDx)

Multiviral Pathogen Detection System to Revolutionize Rapid Infectious Disease Diagnosis and Tracking

An innovative molecular testing technology platform designed to rapidly and simultaneously detect and differentiate multiple pathogens with high sensitivity and specificity is poised to help revolutionize rapid infectious disease diagnosis and tracking worldwide. More...
22 Jun 2022
Gold Member
Automatic Hematology Analyzer
DH-800 Series
Gold Member
Blood Gas Analyzer
Stat Profile pHOx
Human Estradiol Assay
Human Estradiol CLIA Kit
Gold Member
Collection and Transport System
PurSafe Plus®


Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.
GLOBE SCIENTIFIC, LLC